First case report of ensartinib in a patient with metastatic ALK rearranged lung cancer with ALK I1171N mutation: a case report
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
First case report of ensartinib in a patient with metastatic ALK rearranged lung cancer with ALK I1171N mutation: a case report ; volume:21 ; number:1 ; day:2 ; month:3 ; year:2023 ; pages:1-4 ; date:12.2023
World journal of surgical oncology ; 21, Heft 1 (2.3.2023), 1-4, 12.2023
- Urheber
-
Yang, Shuang
Feng, Weineng
Deng, Yanming
Liang, Jianmiao
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12957-023-02935-9
- URN
-
urn:nbn:de:101:1-2023121409253401081967
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yang, Shuang
- Feng, Weineng
- Deng, Yanming
- Liang, Jianmiao
- SpringerLink (Online service)
Ähnliche Objekte (12)
Intrathecal pemetrexed for leptomeningeal metastases in a patient with ALK-rearranged lung adenocarcinoma: a case report
Malakoplakia with aberrant ALK expression by immunohistochemistry: a case report
Epithelioid cell histiocytoma with SQSTM1-ALK fusion: a case report
Effective Crizotinib schedule for an elderly patient with ALK rearranged non-small-cell lung cancer: a case report
Successful treatment with alectinib after crizotinib-induced hepatitis in ALK-rearranged advanced lung cancer patient: a case report
5′ ALK Amplification in Neuroblastoma: A Case Report
Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants
Crizotinib-induced osteitis mimicking bone metastasis in a stage IV ALK-rearranged NSCLC patient: a case report
ALK-rearranged lung squamous cell carcinoma responding to alectinib: a case report and review of the literature
Activity of crizotinib over choroidal metastases in Non-Small-Cell Lung Cancer (NSCLC)-ALK rearranged: a case report
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK ‐rearranged lung cancer
Primary Resistance to ALK Inhibitors in a Patient with Nonsmall Cell Lung Cancer with ALK Rearrangement: A Case Report with Review of Literature
Intrathecal pemetrexed for leptomeningeal metastases in a patient with ALK-rearranged lung adenocarcinoma: a case report
Malakoplakia with aberrant ALK expression by immunohistochemistry: a case report
Epithelioid cell histiocytoma with SQSTM1-ALK fusion: a case report
Effective Crizotinib schedule for an elderly patient with ALK rearranged non-small-cell lung cancer: a case report
Successful treatment with alectinib after crizotinib-induced hepatitis in ALK-rearranged advanced lung cancer patient: a case report
5′ ALK Amplification in Neuroblastoma: A Case Report
Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants
Crizotinib-induced osteitis mimicking bone metastasis in a stage IV ALK-rearranged NSCLC patient: a case report
ALK-rearranged lung squamous cell carcinoma responding to alectinib: a case report and review of the literature
Activity of crizotinib over choroidal metastases in Non-Small-Cell Lung Cancer (NSCLC)-ALK rearranged: a case report
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK ‐rearranged lung cancer
Primary Resistance to ALK Inhibitors in a Patient with Nonsmall Cell Lung Cancer with ALK Rearrangement: A Case Report with Review of Literature
Intrathecal pemetrexed for leptomeningeal metastases in a patient with ALK-rearranged lung adenocarcinoma: a case report
Malakoplakia with aberrant ALK expression by immunohistochemistry: a case report
Epithelioid cell histiocytoma with SQSTM1-ALK fusion: a case report
Effective Crizotinib schedule for an elderly patient with ALK rearranged non-small-cell lung cancer: a case report
Successful treatment with alectinib after crizotinib-induced hepatitis in ALK-rearranged advanced lung cancer patient: a case report
5′ ALK Amplification in Neuroblastoma: A Case Report
Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants
Crizotinib-induced osteitis mimicking bone metastasis in a stage IV ALK-rearranged NSCLC patient: a case report
ALK-rearranged lung squamous cell carcinoma responding to alectinib: a case report and review of the literature
Activity of crizotinib over choroidal metastases in Non-Small-Cell Lung Cancer (NSCLC)-ALK rearranged: a case report
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK ‐rearranged lung cancer